An exploration of the role of pharmacists within general practice clinics: the protocol for the pharmacists in practice study (PIPS)
- PMID: 22876813
- PMCID: PMC3470952
- DOI: 10.1186/1472-6963-12-246
An exploration of the role of pharmacists within general practice clinics: the protocol for the pharmacists in practice study (PIPS)
Abstract
Background: Medication-related problems are a serious concern in Australian primary care. Pharmacist interventions have been shown to be effective in identifying and resolving these problems. Collaborative general practitioner-pharmacist services currently available in Australia are limited and underused. Limitations include geographical isolation of pharmacists and lack of communication and access to patient information. Co-location of pharmacists within the general practice clinics is a possible solution. There have been no studies in the Australian setting exploring the role of pharmacists within general practice clinics.The aim of this study is to develop and test a multifaceted practice pharmacist role in primary care practices to improve the quality use of medicines by patients and clinic staff.
Methods/design: This is a multi-centre, prospective intervention study with a pre-post design and a qualitative component. A practice pharmacist will be located in each of two clinics and provide short and long patient consultations, drug information services and quality assurance activities. Patients receiving long consultation with a pharmacist will be followed up at 3 and 6 months. Based on sample size calculations, at least 50 patients will be recruited for long patient consultations across both sites. Outcome measures include the number, type and severity of medication-related problems identified and resolved; medication adherence; and patient satisfaction. Brief structured interviews will be conducted with patients participating in the study to evaluate their experiences with the service. Staff collaboration and satisfaction with the service will be assessed.
Discussion: This intervention has the potential to optimise medication use in primary care clinics leading to better health outcomes. This study will provide data about the effectiveness of the proposed model for pharmacist involvement in Australian general practice clinics, that will be useful to guide further research and development in this area.
Trial registration: Australian New Zealand Clinical Trials Registry: ACTRN12612000742875.
Similar articles
-
Pharmacist consultations in general practice clinics: the Pharmacists in Practice Study (PIPS).Res Social Adm Pharm. 2014 Jul-Aug;10(4):623-32. doi: 10.1016/j.sapharm.2013.08.005. Epub 2013 Oct 2. Res Social Adm Pharm. 2014. PMID: 24095088 Clinical Trial.
-
A pharmacist-led intervention for increasing the uptake of Home Medicines Review (HMR) among residents of retirement villages (PHARMER): protocol for a cluster randomised controlled trial.BMC Health Serv Res. 2011 Oct 31;11:292. doi: 10.1186/1472-6963-11-292. BMC Health Serv Res. 2011. PMID: 22040307 Free PMC article. Clinical Trial.
-
Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).BMC Fam Pract. 2015 Jul 2;16:76. doi: 10.1186/s12875-015-0296-8. BMC Fam Pract. 2015. PMID: 26135582 Free PMC article. Clinical Trial.
-
Clinical pharmacists in Dutch general practice: an integrated care model to provide optimal pharmaceutical care.Int J Clin Pharm. 2021 Oct;43(5):1155-1162. doi: 10.1007/s11096-021-01304-4. Epub 2021 Jul 3. Int J Clin Pharm. 2021. PMID: 34216352 Free PMC article. Review.
-
Community pharmacist led medication reviews in the UK: A scoping review of the medicines use review and the new medicine service literatures.Res Social Adm Pharm. 2020 Feb;16(2):111-122. doi: 10.1016/j.sapharm.2019.04.010. Epub 2019 Apr 19. Res Social Adm Pharm. 2020. PMID: 31085141
Cited by
-
Evaluation of General Practice Pharmacists: Study Protocol to Assess Interprofessional Collaboration and Team Effectiveness.Int J Environ Res Public Health. 2021 Jan 22;18(3):966. doi: 10.3390/ijerph18030966. Int J Environ Res Public Health. 2021. PMID: 33499259 Free PMC article.
-
Comparison of drug-related problem risk assessment tools for older adults: a systematic review.Eur J Clin Pharmacol. 2020 Mar;76(3):337-348. doi: 10.1007/s00228-019-02796-w. Epub 2019 Dec 10. Eur J Clin Pharmacol. 2020. PMID: 31822957
-
The development of a role description and competency map for pharmacists in an interprofessional care setting.Int J Clin Pharm. 2019 Apr;41(2):391-407. doi: 10.1007/s11096-019-00808-4. Epub 2019 Mar 16. Int J Clin Pharm. 2019. PMID: 30879217 Review.
-
Feasibility of a collaborative pharmacist prescribing model for patients with chronic disease(s) attending Australian general practices: a preliminary study.Int J Clin Pharm. 2023 Apr;45(2):502-508. doi: 10.1007/s11096-022-01488-3. Epub 2022 Nov 7. Int J Clin Pharm. 2023. PMID: 36342565
-
Non-dispensing pharmacists integrated into general practices as a new interprofessional model: a qualitative evaluation of general practitioners' experiences and views.BMC Health Serv Res. 2024 Apr 23;24(1):502. doi: 10.1186/s12913-024-10703-y. BMC Health Serv Res. 2024. PMID: 38654340 Free PMC article.
References
-
- Miller GC, Britth HC, Valenti L. Adverse drug events in general practice patients in Australia. Med J Aust. 2006;184:321–324. - PubMed
-
- Bhasale AL, Miller GC, Reid SE, Britt HC. Analysing potential harm in Australian general practice: an incident-monitoring study. Med J Aust. 1998;169:73–76. - PubMed
-
- Avery T, Barber N, Ghaleb M, Dean Franklin B, Armstrong S, Crowe S, Dhillon S, Freyer A, Howard R, Pezzolesi C, Investigating the prevalence and causes of prescribing errors in general practice: the PRACtICe study. Gen Med Council. 2012.
-
- Gilbert AL, Roughead EE, Beilby J, Mott K, Barratt JD. Collaborative medication management services: improving patient care. Med J Aust. 2002;177:189–192. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources